{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:22:34Z","timestamp":1784240554480,"version":"3.55.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11,11]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Enterocutaneous fistulas (ECF) are rare sequelae of Crohn\u2019s disease (CD) that occur either postoperatively or spontaneously. ECFs are associated with high morbidity and mortality. This systematic literature review assesses the disease burden of CD-related ECF and identifies knowledge gaps around incidence\/prevalence, treatment patterns, clinical outcomes, healthcare resource utilization (HCRU), and patient-reported outcomes (PROs).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>English language articles published in PubMed and Embase in the past 10 years that provided data and insight into the disease burden of CD-related ECF (PROSPERO Registration number: CRD42020177732) were identified. Prespecified search and eligibility criteria guided the identification of studies by two reviewers who also assessed risk of bias.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>In total, 582 records were identified; 316 full-text articles were assessed. Of those, eight studies met a priori eligibility criteria and underwent synthesis for this review. Limited epidemiologic data estimated a prevalence of 3265 persons with ECF in the USA in 2017. Clinical response to interventions varied, with closure of ECF achieved in 10% to 62.5% of patients and recurrence reported in 0% to 50% of patients. Very little information on HCRU is available, and no studies of PROs in this specific population were identified.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The frequency, natural history, and outcomes of ECF are poorly described in the literature. The limited number of studies included in this review suggest a high treatment burden and risk of substantial complications. More robust, population-based research is needed to better understand the epidemiology, natural history, and overall disease burden of this rare and debilitating complication of CD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000030963","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T14:01:27Z","timestamp":1668693687000},"page":"e30963","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["A systematic review of epidemiology and outcomes of Crohn\u2019s disease-related enterocutaneous fistulas"],"prefix":"10.1097","volume":"101","author":[{"given":"Kristy","family":"Iglay","sequence":"first","affiliation":[{"name":"CERobs Consulting, LLC, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8387-9342","authenticated-orcid":false,"given":"Dimitri","family":"Bennett","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceuticals, Cambridge, MA"},{"name":"Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Kappelman","sequence":"additional","affiliation":[{"name":"Pediatric Gastroenterology, University of North Carolina, Chapel Hill School of Medicine, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamika","family":"Reynolds","sequence":"additional","affiliation":[{"name":"CERobs Consulting, LLC, Chapel Hill, NC"},{"name":"Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Aldridge","sequence":"additional","affiliation":[{"name":"CERobs Consulting, LLC, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitra","family":"Karki","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceuticals, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne F.","family":"Cook","sequence":"additional","affiliation":[{"name":"CERobs Consulting, LLC, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"S499","DOI":"10.14309\/00000434-201410002-01687","article-title":"Updated incidence and prevalence of Crohn\u2019s disease and ulcerative colitis in Olmsted County, Minnesota (1970\u20132010): ACG IBD Research Award: 1687.","volume":"109","author":"Shivashankar","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ejcn.2014.31","article-title":"Predictors of response to enteral nutrition in abdominal enterocutaneous fistula patients with Crohn\u2019s disease.","volume":"68","author":"Yan","year":"2014","journal-title":"Eur J Clin Nutr"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/gast.2002.32362","article-title":"The natural history of fistulizing Crohn\u2019s disease in Olmsted County, Minnesota.","volume":"122","author":"Schwartz","year":"2002","journal-title":"Gastroenterology"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.","volume":"390","author":"Ng","year":"2018","journal-title":"Lancet"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4321\/S1130-01082013000100002","article-title":"Enterocutaneous fistulas and Crohn\u2019s disease: clinical characteristics and response to treatment.","volume":"105","author":"Gomez-Senent","year":"2013","journal-title":"Rev Esp Enferm Dig"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/codi.12473","article-title":"Definitive surgical closure of enterocutaneous fistula: outcome and factors predictive of increased postoperative morbidity.","volume":"16","author":"Ravindran","year":"2014","journal-title":"Colorectal Dis"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1055\/s-0036-1580732","article-title":"Enterocutaneous fistula: proven strategies and updates.","volume":"29","author":"Gribovskaja-Rupp","year":"2016","journal-title":"Clin Colon Rectal Surg"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/2050640613487194","article-title":"Fistulizing Crohn\u2019s disease: diagnosis and management.","volume":"1","author":"Gecse","year":"2013","journal-title":"United European Gastroenterol J"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-0030-1263062","article-title":"Complications of enterocutaneous fistulas and their management.","volume":"23","author":"Williams","year":"2010","journal-title":"Clin Colon Rectal Surg"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ajg.2014.183","article-title":"Long-term outcome of enterocutaneous fistula in patients with Crohn\u2019s disease treated with anti-TNF therapy: a cohort study from the GETAID.","volume":"109","author":"Amiot","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"R14-20250504","first-page":"S235","article-title":"Retrospective analysis of enterocutaneous fistula management in IBD.","volume":"184","author":"Boyle","year":"2015","journal-title":"Ir J Med Sci"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/ibd\/izz056","article-title":"Prevalence of fistulizing Crohn\u2019s disease in the United States: estimate from a systematic literature review attempt and population-based database analysis.","volume":"25","author":"Schwartz","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1046\/j.1365-2036.2003.01561.x","article-title":"The clinical course of fistulating Crohn\u2019s disease.","volume":"17","author":"Bell","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1445-2197.2009.05086.x","article-title":"Enterocutaneous fistula: a single-centre experience.","volume":"80","author":"Gyorki","year":"2010","journal-title":"ANZ J Surg"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1007\/s00268-010-0568-3","article-title":"Intra-abdominal fistulas in surgically treated Crohn\u2019s disease patients.","volume":"34","author":"Yoon","year":"2010","journal-title":"World J Surg"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ejcn.2014.16","article-title":"Preoperative exclusive enteral nutrition reduces the postoperative septic complications of fistulizing Crohn\u2019s disease.","volume":"68","author":"Li","year":"2014","journal-title":"Eur J Clin Nutr"},{"key":"R20-20250504","first-page":"e7789","article-title":"Enterocutaneous fistula: a simplified clinical approach.","volume":"12","author":"Tuma","year":"2020","journal-title":"Cureus"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030963","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:01:30Z","timestamp":1746334890000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":19,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000030963","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,11]]}}}